MMSI NASDAQ
Merit Medical Systems, Inc.
1W: +2.6%
1M: +7.5%
3M: +15.7%
YTD: +8.2%
1Y: +13.0%
3Y: +44.3%
5Y: +33.9%
$93.53
-0.67 (-0.71%)
Weekly Expected Move ±3.7%
$86
$90
$93
$97
$100
Credit Risk of going bust: lower than 81% of companies Debt: 12.8% of company value Bonds: $91.0M held by 33 funds → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.81 (down 99.1%), Merit Medical Systems, Inc. would be worth roughly what it owes.
Total debt $820.1M against a stock market value of $5.58B.
Distance to default 10.00 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $368.1M (short-term plus half of long-term), stock volatility 29.6%; Altman Z 4.44. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $0.81 (down 99.1%), Merit Medical Systems, Inc. would be worth roughly what it owes.
Total debt $820.1M against a stock market value of $5.58B.
Distance to default 10.00 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $368.1M (short-term plus half of long-term), stock volatility 29.6%; Altman Z 4.44. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2023-06-08
Earliest Filing
2025-05-20
Latest Filing
target: 4
partner: 1
Counterparties (Filed by MMSI)
5 relationshipsCompanies named in MMSI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Biolife, L.L.C. | — | target | Target company acquired by Merit Medical Systems, Inc. in a merger for $120 million. | 2025-05-20 | View |
| Biolife Delaware, L.L.C. | — | target | Surviving entity of the merger, formerly FL Biolife, acquired by Merit Medical Systems, Inc. | 2025-05-20 | View |
| Shareholder Representative Services LLC | — | partner | Party to the Agreement and Plan of Merger alongside Merit and Biolife entities. | 2025-05-20 | View |
| AngioDynamics, Inc. | ANGO | target | Target of asset acquisition for dialysis catheter products and BioSentry Biopsy Tract Sealant System | 2023-06-08 | View |
| Bluegrass Vascular Technologies, Inc. | — | target | Target of asset acquisition for Surfacer Inside-Out Access Catheter System | 2023-06-08 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-20 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-07-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-05-19 | Officer/Director Change; Bylaws Amendment; Shareholder Vote; Regulation FD; Exhibits | View | |
| 2026-04-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-13 | Regulation FD; Exhibits | View | |
| 2026-04-01 | Regulation FD; Exhibits | View | |
| 2026-02-24 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-08 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-11-13 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-03 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-10-30 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-10-17 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-10-10 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-07-30 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-11 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-05-20 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Regulation | Agreement | View |
| 2025-05-19 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-04-24 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-02-25 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-01-28 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR